Last edition
News about "autoimmune disorders"
US-based biotechnology company Kaigene has signed an exclusive global licensing agreement with South Korean biopharmaceutical giant Celltrion to develop and commercialise two of its nonclinical-stage antibody assets, KG006 and KG002.
Autoimmune Disorders | 04/11/2025 | By Dineshwori
Lupin Introduces Rymti Biosimilar Etanercept in Canada
Lupin Ltd. has developed Rymti, Lupin’s first biosimilar in Canada, through its partner Sandoz Canada (Sandoz).
Autoimmune Disorders | 06/05/2024 | By Aishwarya | 411
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy